AMN082, a positive allosteric modulator of the mGlu7 receptor, enhances the antidepressant-like activity of scopolamine in the tail suspension test

被引:0
|
作者
Podkowa, K. [1 ]
Podkowa, A. [2 ]
Salat, K. [2 ]
Pilc, A. [1 ]
Palucha-Poniewiera, A. [1 ]
机构
[1] Polish Acad Sci, Dept Neurobiol, Inst Pharmacol, Krakow, Poland
[2] Jagiellonian Univ, Chair Pharmacodynam, Fac Pharm, Krakow, Poland
关键词
D O I
10.1016/S0924-977X(17)31248-8
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.1.h.011
引用
收藏
页码:S669 / S669
页数:1
相关论文
共 50 条
  • [1] A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats
    Palucha-Poniewiera, Agnieszka
    Pilc, Andrzej
    BEHAVIOURAL BRAIN RESEARCH, 2013, 238 : 109 - 112
  • [2] The role of GABAergic transmission in the behavioral effects of mGlu7 receptor positive modulator, AMN082
    Joanna M. Wierońska
    Andrzej Pilc
    Pharmacological Reports, 2009, 61 : 379 - 379
  • [3] The role of GABAergic transmission in the behavioral effects of mGlu7 receptor positive modulator, AMN082
    Wieronska, Joanna M.
    Pilc, Andrzej
    PHARMACOLOGICAL REPORTS, 2009, 61 (02) : 379 - 379
  • [4] The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice
    Podkowa, Karolina
    Pilc, Andrzej
    Podkowa, Adrian
    Salat, Kinga
    Marciniak, Marcin
    Palucha-Poniewiera, Agnieszka
    NEUROPHARMACOLOGY, 2018, 141 : 214 - 222
  • [5] Positive allosteric modulation of mGlu7 receptors by AMN082 affects sleep and wakefulness in the rat
    Cavas, Maria
    Scesa, Gianluigi
    Francisco Navarro, Jose
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2013, 103 (04) : 756 - 763
  • [6] Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats
    Palucha-Poniewiera, Agnieszka
    Szewczyk, Bernadeta
    Pilc, Andrzej
    NEUROPHARMACOLOGY, 2014, 82 : 59 - 68
  • [7] Impact of the metabotropic glutamate receptor7 (mGlu7) allosteric agonist, AMN082, on fear learning and memory and anxiety-like behavior
    Kotlinska, Jolanta H.
    Lopatynska-Mazurek, Malgorzata
    Gawel, Kinga
    Gabka, Patrycja
    Jenda-Wojtanowska, Malgorzata
    Kruk-Slomka, Marta
    Marszalek-Grabska, Marta
    Danilczuk, Zofia
    Kedzierska, Ewa
    Talareka, Sylwia
    Listos, Joanna
    Gibula-Tarlowska, Ewa
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 858
  • [8] The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling
    Bradley, Stefania Risso
    Uslaner, Jason M.
    Flick, Rose B.
    Lee, Ariel
    Groover, Kristina M.
    Hutson, Peter H.
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 101 (01) : 35 - 40
  • [9] The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
    Rizzo, Stacey J. Sukoff
    Leonard, Sarah K.
    Gilbert, Adam
    Dollings, Paul
    Smith, Deborah L.
    Zhang, Mei-Yi
    Di, Li
    Platt, Brian J.
    Neal, Sarah
    Dwyer, Jason M.
    Bender, Corey N.
    Zhang, Jean
    Lock, Tim
    Kowal, Dianne
    Kramer, Angela
    Randall, Andrew
    Huselton, Christine
    Vishwanathan, Karthick
    Tse, Susanna Y.
    Butera, John
    Ring, Robert H.
    Rosenzweig-Lipson, Sharon
    Hughes, Zoe A.
    Dunlop, John
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01): : 345 - 352
  • [10] The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands
    Gawel, K.
    Jenda-Wojtanowska, M.
    Gibula-Bruzda, E.
    Kedzierska, E.
    Filarowska, J.
    Marszalek-Grabska, M.
    Wojtanowski, K. K.
    Komsta, L.
    Talarek, S.
    Kotlinska, J. H.
    PHYSIOLOGY & BEHAVIOR, 2018, 185 : 112 - 120